1. Home
  2. GRNQ vs ONCO Comparison

GRNQ vs ONCO Comparison

Compare GRNQ & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • ONCO
  • Stock Information
  • Founded
  • GRNQ 2013
  • ONCO 2018
  • Country
  • GRNQ Malaysia
  • ONCO United States
  • Employees
  • GRNQ N/A
  • ONCO N/A
  • Industry
  • GRNQ EDP Services
  • ONCO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • ONCO Health Care
  • Exchange
  • GRNQ Nasdaq
  • ONCO Nasdaq
  • Market Cap
  • GRNQ 8.9M
  • ONCO 9.4M
  • IPO Year
  • GRNQ 2018
  • ONCO 2022
  • Fundamental
  • Price
  • GRNQ $1.06
  • ONCO $0.65
  • Analyst Decision
  • GRNQ
  • ONCO
  • Analyst Count
  • GRNQ 0
  • ONCO 0
  • Target Price
  • GRNQ N/A
  • ONCO N/A
  • AVG Volume (30 Days)
  • GRNQ 335.9K
  • ONCO 10.5M
  • Earning Date
  • GRNQ 03-27-2025
  • ONCO 12-10-2024
  • Dividend Yield
  • GRNQ N/A
  • ONCO N/A
  • EPS Growth
  • GRNQ N/A
  • ONCO N/A
  • EPS
  • GRNQ N/A
  • ONCO N/A
  • Revenue
  • GRNQ $2,727,344.00
  • ONCO $1,870,605.00
  • Revenue This Year
  • GRNQ N/A
  • ONCO N/A
  • Revenue Next Year
  • GRNQ N/A
  • ONCO N/A
  • P/E Ratio
  • GRNQ N/A
  • ONCO N/A
  • Revenue Growth
  • GRNQ N/A
  • ONCO N/A
  • 52 Week Low
  • GRNQ $0.80
  • ONCO $0.32
  • 52 Week High
  • GRNQ $2.24
  • ONCO $21.40
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 49.42
  • ONCO 52.07
  • Support Level
  • GRNQ $0.97
  • ONCO $0.51
  • Resistance Level
  • GRNQ $1.28
  • ONCO $0.67
  • Average True Range (ATR)
  • GRNQ 0.08
  • ONCO 0.09
  • MACD
  • GRNQ -0.01
  • ONCO 0.03
  • Stochastic Oscillator
  • GRNQ 37.40
  • ONCO 36.57

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: